PHASE III-MULTICENTER TRIAL EPIRUBICIN-PACLITAXEL VS. EPIRUBICIN-CYCLOPHOSPHAMIDE AS FIRST-LINE THERAPY OF METASTATIC BREAST-CANCER - AN AGO STUDY PROTOCOL
W. Schroeder et al., PHASE III-MULTICENTER TRIAL EPIRUBICIN-PACLITAXEL VS. EPIRUBICIN-CYCLOPHOSPHAMIDE AS FIRST-LINE THERAPY OF METASTATIC BREAST-CANCER - AN AGO STUDY PROTOCOL, Annals of oncology, 9, 1998, pp. 560-560